Lv4
408 积分 2023-11-17 加入
Cancer Immunoediting in the Era of Immuno-oncology
15小时前
待确认
TAS-102, Irinotecan, and bevacizumab in pre-treated metastatic colorectal cancer (TABAsCO), a phase II clinical trial
1个月前
已完结
Neoadjuvant Sintilimab and Chemotherapy for Resectable Stage IIIA Non-Small Cell Lung Cancer
1个月前
已完结
Cancer immunoediting and resistance to T cell-based immunotherapy
2个月前
已完结
Modulating Treg stability to improve cancer immunotherapy
2个月前
已完结
TCR Repertoire Diversity of Peripheral PD-1+CD8+ T Cells Predicts Clinical Outcomes after Immunotherapy in Patients with Non–Small Cell Lung Cancer
3个月前
已完结
Tumour-associated macrophages as treatment targets in oncology
5个月前
已完结
Myeloid-derived itaconate suppresses cytotoxic CD8+ T cells and promotes tumour growth
6个月前
已完结
RBFOX2 deregulation promotes pancreatic cancer progression and metastasis through alternative splicing
8个月前
已完结
p53 Gain-of-Function Mutation Induces Metastasis via BRD4-Dependent CSF-1 Expression
8个月前
已完结
皖公网安备34019202002308
